Occupational Therapists in South Setauket, NY Accepting Medicare

6 Occupational Therapists found. Showing 1 - 6

Ms. Allison Chemick, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1 Jefferson Ferry Dr, South Setauket, NY 11720 Phone: 631-650-2600

Mrs. Jodi Lynne Pobliner Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6 Brookfield Ln, South Setauket, NY 11720 Phone: 631-846-3304

Darlene Patricia O'reilly, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4089 Nesconset Hwy, South Setauket, NY 11720 Phone: 631-331-1988

Isabel Melazzini, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14 Valiant Dr, South Setauket, NY 11720 Phone: 631-696-3240

Kara Fiederlein Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1 Jefferson Ferry Dr, South Setauket, NY 11720 Phone: 631-650-2600

Jessica Ferrier, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1 Jefferson Ferry Dr, South Setauket, NY 11720 Phone: 631-650-2600

News Archive

3 rules of thumb to reduce childhood obesity

Kristopher Kaliebe, MD, Clinical Assistant Professor of Psychiatry at the LSU Health Sciences Center New Orleans School of Medicine, offers parents and caregivers three simple family-oriented goals to overcome the complex problem of childhood obesity and related mental disorders.

Study finds uninsured trauma patients much more likely to die in ER

"Uninsured patients with traumatic injuries, such as car crashes, falls and gunshot wounds, were almost twice as likely to die in the hospital as similarly injured patients with health insurance, according to a troubling new study," The Associated Press reports. "The findings by Harvard University researchers surprised doctors and health experts who have believed emergency room care was equitable."

Impax announces data from IPX066 Phase III study on Parkinson's

Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc., today announced that data from the ASCEND-PD Phase III clinical study involving IPX066 will be presented in a Platform Presentation at the 64th Annual Meeting of the American Academy of Neurology in New Orleans, Louisiana, held from April 21 to April 28.

Scientists now closer to produce drugs to fix disease-causing mutations, spare healthy genes

Inherited diseases such as cystic fibrosis can be caused by genetic "nonsense mutations" that disrupt the way human cells make proteins. David Bedwell, Ph.D., a professor in the University of Alabama at Birmingham Department of Microbiology, says scientists are now closer to producing drugs that will fix this disruption and drastically improve treatment of genetic disease.

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

Read more Medical News

› Verified 5 days ago